These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neutropenia in an HIV-1-infected renal transplant recipient treated with zidovudine. Erice A; Rhame FS; Dunn DL; Chinnock B; Balfour HH JAMA; 1988 Jun; 259(23):3407-8. PubMed ID: 3286912 [No Abstract] [Full Text] [Related]
6. The blood transfusion service and zidovudine treatment for AIDS. Costello C; Mir N; Luckit J Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1486. PubMed ID: 3121073 [No Abstract] [Full Text] [Related]
7. Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy. Jacobson MA; de Miranda P; Gordon SM; Blum MR; Volberding P; Mills J J Infect Dis; 1988 Aug; 158(2):489-90. PubMed ID: 3261316 [No Abstract] [Full Text] [Related]
8. Possible drug interaction during therapy with azidothymidine and acyclovir for AIDS. Bach MC N Engl J Med; 1987 Feb; 316(9):547. PubMed ID: 3468354 [No Abstract] [Full Text] [Related]
9. Nail pigmentation and azidothymidine. Vaiopoulos G; Mangakis J; Karabinis A; Kourtis A; Fourtounis P; Fessas P Ann Intern Med; 1988 May; 108(5):777. PubMed ID: 3162791 [No Abstract] [Full Text] [Related]
10. Nail pigmentation changes associated with azidothymidine (zidovudine). Furth PA; Kazakis AM Ann Intern Med; 1987 Sep; 107(3):350. PubMed ID: 3497596 [No Abstract] [Full Text] [Related]
11. Nail pigmentation in the acquired immunodeficiency syndrome (AIDS). Panwalker AP Ann Intern Med; 1987 Dec; 107(6):943-4. PubMed ID: 3479923 [No Abstract] [Full Text] [Related]
12. Can AZT treatment in AIDS patients aggravate pre-existing CMV retinitis? Büchi ER; Bovey EH; Michel AE; Erard PA; Chave JP Br J Ophthalmol; 1988 Mar; 72(3):239-40. PubMed ID: 2833304 [No Abstract] [Full Text] [Related]
13. A little more to improve safety and efficiency of AZT in AIDS therapy. Camsonne R; Hurrault de Ligny B; Letellier P Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):683. PubMed ID: 3481360 [No Abstract] [Full Text] [Related]
14. Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. A challenge to the medical and pharmaceutical communities. Brook I JAMA; 1987 Sep; 258(11):1517. PubMed ID: 3306004 [No Abstract] [Full Text] [Related]
15. Update on AZT for AIDS. Med Lett Drugs Ther; 1987 Dec; 29(755):113-4. PubMed ID: 3479677 [No Abstract] [Full Text] [Related]
16. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Walker RE; Parker RI; Kovacs JA; Masur H; Lane HC; Carleton S; Kirk LE; Gralnick HR; Fauci AS Ann Intern Med; 1988 Mar; 108(3):372-6. PubMed ID: 3422548 [TBL] [Abstract][Full Text] [Related]
17. [Azidothymidine and HIV infection]. Offerhaus L Ned Tijdschr Geneeskd; 1987 May; 131(22):934-6. PubMed ID: 3037393 [No Abstract] [Full Text] [Related]
18. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Gill PS; Rarick M; Brynes RK; Causey D; Loureiro C; Levine AM Ann Intern Med; 1987 Oct; 107(4):502-5. PubMed ID: 3477107 [TBL] [Abstract][Full Text] [Related]
19. Acute meningo-encephalitis on dose reduction of zidovudine. Helbert M; Robinson D; Peddle B; Forster S; Kocsis A; Jeffries D; Pinching AJ Lancet; 1988 Jun; 1(8597):1249-52. PubMed ID: 2897518 [TBL] [Abstract][Full Text] [Related]
20. Effect of zidovudine on serum human immunodeficiency virus antigen levels in symptom-free subjects. de Wolf F; Lange JM; Goudsmit J; Cload P; de Gans J; Schellekens PT; Coutinho RA; Fiddian AP; van der Noordaa J Lancet; 1988 Feb; 1(8582):373-6. PubMed ID: 2893187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]